市场调查报告书
商品编码
1410818
输尿管镜市场:按细分市场划分的规模、份额、法规、报销、程序、安装基础、到 2033 年的预测Ureteroscopes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures, Installed Base and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
输尿管镜的市场规模受到多种因素的推动,例如人口老化、肾结石患者数量的增加以及肾臟、输尿管和膀胱的其他疾病。
全球患有泌尿系统疾病的人数持续增加,估计全球有超过2亿人患有肾臟疾病。输尿管镜是一种用于向这些患者给药的装置。随着泌尿系统疾病患者数量的增加,需要输尿管镜的医院数量也会增加,输尿管镜市场可望扩大。
该报告深入探讨了全球输尿管镜市场,包括竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响以及区域和国家趋势。
Ureteroscopes Market Size by Segments, Share, Regulatory, Reimbursement, Procedures, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within Endoscopy Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Ureteroscopes market for the year 2020 and beyond. The Ureteroscopes market is driven by a variety of factors, including a growing aging population, increase in patients with kidney stones, and other conditions of the kidney, ureter, and bladder.
The global population with urological disorders continues to increase with more than 200 million people worldwide estimated to have kidney disorders. Ureteroscopes are devices used to administer medication to these patients. This rising number of patients with urological disorders is expect to result in a larger number of hospitals that require Ureteroscopes, resulting in an increase in the market for Ureteroscopes.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Ureteroscopes and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: KARL STORZ SE & Co KG, Hoya Corp, Olympus Corp, National Advanced Endoscopy Devices, Inc., Richard Wolf GmbH, Stryker Corp, Boston Scientific Corp, NeoScope Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable